Download PDF
Geburtshilfe Frauenheilkd 2003; 63(10): R205-R228
DOI: 10.1055/s-2004-820852
GebFra-Refresher

Georg Thieme Verlag Stuttgart · New York

Gestationsbedingte Trophoblasterkrankungen

L.-C. Horn1 , S. Ackermann2 , M. W. Beckmann2 , J. Einenkel3
  • 1Institut für Pathologie und Gynäkologie, Universität Leipzig
  • 2Universitäts-Frauenklinik Erlangen
  • 3Universitäts-Frauenklinik Leipzig
Further Information

Publication History

Publication Date:
10 October 2003 (online)

Also available at
    Permissions and Reprints

Die gestationsbedingten Trophoblasterkrankungen

Zu den gestationsbedingten Trophoblasterkrankungen zählen: Partialmole, Blasenmole, trophoblastäre Neoplasien. Kennzeichnend sind eine Fehldifferenzierung und/oder Proliferation des Trophoblastepithels.
, die in der angloamerikanischen Literatur als gestational trophoblastic disease (gestationsbedingte Trophoblasterkrankungen) bezeichnet werden, umfassen eine in Bezug auf ihre Genese und klinische Bedeutung heterogene Gruppe von Krankheitsbildern, die durch eine Fehldifferenzierung und/oder Proliferation des Trophoblastepithels gekennzeichnet ist. Mit einem klinisch sehr unterschiedlichen Erscheinungsbild handelt es sich sowohl um benigne als auch hochmaligne Erkrankungen.

In Abhängigkeit vom klinischen Bild und ihrer Morphologie werden in Anlehnung an die WHO-Klassifikation [[1]] eine Reihe Läsionen unterschieden (Tab. [1]).

Tab. 1 WHO-Klassifikation gestationsbedingter Trophoblasterkrankungen [1] 1. villöse Trophoblasterkrankungen Partialmole Blasenmole (komplette Mole) invasive Mole (destruierende Mole) 2. nicht-villöse Trophoblasterkrankungen Chorionkarzinom Plazentabetttumor (placental site trophoblastic tumor; PSTT) epitheloider Trophoblasttumor (epitheloid trophoblastic tumor; ETT) Plazentabettknötchen (placental site nodule; PSN) hyperplastische Implantationsstelle des Plazentabettes (sog. exaggerated placental site; EPS)

Der Terminus gestationsbedingte Trophoblasterkrankung ist ein Überbegriff und beinhaltet die Partial- und Blasenmole sowie die gestationsbedingten trophoblastären Neoplasien (GTN).

Literatur

  • 1 Scully R E, Bonfiglio T A, Kurman R J, Silverberg S G, Wilkinson E J. WHO - Histological Typing of Female Genital Tract Tumours. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest; Springer 1994
    Search in Google Scholar
  • 2 Ngan H YS, Odicino F, Maisonneuve P, Beller U, Benedt J L, Heintz A PM, Pecorelli S, Siderei M, Creasman W T. Gestational trophoblastic disease.  J Epidemiol Biostat. 2001;  6 177-184
    PubMedSearch in Google Scholar
  • 3 DiCintio E, Parazzini F, Rosa C, Chatenoud L, Benzi G. The epidemiology of gestational trophoblastic disease.  Gen Diagn Pathol. 1997;  143 103-108
    PubMedSearch in Google Scholar
  • 4 Kim S J, Bae S N, Kim J H, Kim C J, Han K T, Chung J K, Lee J M. Epidemiology and time trends of gestational trophoblastic disease in Korea.  Int J Gynaecol Obstet. 1998;  60 (Suppl 1) S33-38
    CrossrefPubMedSearch in Google Scholar
  • 5 Kohorn E I. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assesssment.  Int J Gynecol Cancer. 2001;  11 73-77
    PubMedSearch in Google Scholar
  • 6 Horn L C, Rosenkranz M, Bilek K. Wertigkeit der Plazentahistologie für die Erkennung genetisch bedingter Aborte.  Z Geburtsh Perinatol. 1991;  195 47-53
    PubMedSearch in Google Scholar
  • 7 Horn L C, Emmrich P, Bilek K, Bruder E. Der frühe plazentare Trophoblast: II. Tumorförmige Störungen der trophoblastären Entwicklung.  Zentralbl Gynäkol. 1996;  118 591-597
    PubMedSearch in Google Scholar
  • 8 Seckl M J, Fisher R A, Salerno G, Rees H, Paradinas F J, Foskett M, Newlands E S. Choriocarcinoma and partial hydatidiform moles.  Lancet. 2000;  356 1443-1444
    PubMedSearch in Google Scholar
  • 9 Bilek K, Horn L C, Abu Hmeidan F, Pretzsch G. Gestationsbedingte Trophoblasterkrankungen - Ergebnisse der Jahre 1976 - 1992.  Geburtsh Frauenheilk. 1994;  54 519-523
    PubMedSearch in Google Scholar
  • 10 Fox H. Differential diagnosis of hydatidiform mole.  Gen Diagn Pathol. 1997;  143 117-125
    PubMedSearch in Google Scholar
  • 11 Kashimura Y, Kashimura M, Masamichi K, Sugimori H, Tsukamoto N, Matsuyama T, Matsukama K, Kamora T, Saito T, Kawano H, Nose R. Prophylactic chemotherapy for hydatidiform mole.  Cancer. 1986;  58 624-629
    PubMedSearch in Google Scholar
  • 12 Seckl M J, Newlands E S. Treatment of gestational trophoblastic disease.  Gen Diagn Pathol. 1997;  143 159-171
    PubMedSearch in Google Scholar
  • 13 Lan Z, Hongzaho S, Xiuyu Y, Yang X. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: A clinical report of 22 patients.  Gynecol Oncol. 2001;  83 146-148
    CrossrefPubMedSearch in Google Scholar
  • 14 Lorigan P C, Sharma S, Bright N, Coleman R E, Hancock B W. Characteristics of women with recurrent molar pregnancies.  Gynecol Oncol. 2000;  78 288-292
    CrossrefPubMedSearch in Google Scholar
  • 15 Kim J H, Park D C, Bae S N, Namkoong S E, Kim S J. Subsequent reproductive experience after treatment for gestational trophoblastic disease.  Gynecol Oncol. 1998;  71 108-112
    CrossrefPubMedSearch in Google Scholar
  • 16 Garner E IO, Lipson E, Bernstein M R, Goldstein D P, Berkowitz R S. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor.  J Reprod Med. 2002;  47 380-386
    PubMedSearch in Google Scholar
  • 17 Shih I M, Kurman R J. Epitheloid trophoblastic tumor - a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma.  Am J Surg Pathol. 1998;  22 1393-1403
    CrossrefPubMedSearch in Google Scholar
  • 18 Davis G A, Survit E A, Garay J P, Fortier J J. Sex assignment in gestational trophoblastic neoplasia.  Am J Obstet Gynecol. 1984;  148 722-725
    PubMedSearch in Google Scholar
  • 19 Herbst H, Horn L C, Löning T. Trophoblasterkrankungen und Trophoblasttumoren.  Pathologe. 1999;  20 72-81
    CrossrefPubMedSearch in Google Scholar
  • 20 Bischoff P, Martelli M. Current topic: Proteolysis in the penetration phase of the implantation process.  Placenta. 1992;  13 17-24
    PubMedSearch in Google Scholar
  • 21 Shih I M, Kurman R J. Molecular basis of gestational trophoblastic diseases.  Curr Mol Med. 2002;  2 1-12
    PubMedSearch in Google Scholar
  • 22 Baergen R N. Gestational choriocarcinoma.  Gen Diagn Pathol. 1997;  143 127-141
    PubMedSearch in Google Scholar
  • 23 Fox H, Laurini R N. Intraplacental choriocarcinoma: A report of two cases.  J Clin Pathol. 1988;  41 1085-1088
    PubMedSearch in Google Scholar
  • 24 Horn L C, Bilek K. Histologic classification and staging of gestational trophoblastic disease.  Gen Diagn Pathol. 1997;  143 87-101
    PubMedSearch in Google Scholar
  • 25 Baergen R N, Rutgers J L. Trophoblastic lesions of the placantal site.  Gen Diagn Pathol. 1997;  143 143-158
    PubMedSearch in Google Scholar
  • 26 Huettner P C, Gersell D J. Placental site nodule: A clinicopathologic study of 38 cases.  Int J Gynecol Pathol. 1994;  13 191-198
    PubMedSearch in Google Scholar
  • 27 Shih I M, Seidman J D, Kurman R J. Placental site nodule and characterisation of distinctive types of intermediate trophoblast.  Hum Pathol. 1999;  30 687-694
    CrossrefPubMedSearch in Google Scholar
  • 28 Shih I M, Kurman R J. The pathology of the intermediate trophoblastic tumors and tumorlike lesions.  Int J Gynecol Pathol. 2001;  20 31-47
    CrossrefPubMedSearch in Google Scholar
  • 29 Hui P, Parkash V, Perkins A S, Carcangiu M L. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome.  Lab Invest. 2000;  80 965-972
    PubMedSearch in Google Scholar
  • 30 Newlands E S, Mulholland P J, Holden L, Seckl M J, Rustin G J. Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophpsphamide and vicncristine chemotherapy and patients representing with metastatic placental site trophoblastic tumors.  J Clin Oncol. 2000;  18 854-859
    PubMedSearch in Google Scholar
  • 31 Papadopoulos A J, Foskett M, Seckl M J, McNeish I, Paradinas F J, Rees H, Newlands E S. Twenty-five year's clinical experience with placental site trophoblastic tumors.  J Reprod Med. 2002;  47 460-464
    PubMedSearch in Google Scholar
  • 32 Denny L A, Dehaeck K, Nevin J, Soeters R, van Wuk A L, Megevand E, Block B. Placental site trophoblastic tumor: Three case reports and literature review.  Gynecol Oncol. 1995;  59 300-303
    CrossrefPubMedSearch in Google Scholar
  • 33 Wittekind C, Wagner G. TNM-Klassifikation maligner Tumoren. 5. Aufl. Berlin, Heidelberg, New York; Springer 1997
    Search in Google Scholar
  • 34 Schmidt D, Baijka M, Köchli O, Robbiani M, Stallmach T. Plazentabett-Tumor: Morphologie, Differentialdiagnose und Prognose.  Pathologe. 1995;  16 315-320
    CrossrefPubMedSearch in Google Scholar
  • 35 Hammond C B, Borchert L G, Tyrey L. et al . Treatment of metastatic trophoblastic disease: Good and poor prognosis.  Am J Obstet Gynecol. 1973;  115 4-8
    PubMedSearch in Google Scholar
  • 36 Lurain J R, Brewer Treatment of high-risk gestational trophoblastic disease with methotrexate J I, actinomycin D. and cyclophosphamide chemotherapy . .  Obstet Gynecol. 1985;  65 830-836
    PubMedSearch in Google Scholar
  • 37 Curry S L, Blessing J A, DiSaia P J, Soper J T, Twiggs L B. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in “poor prognosis” metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.  Obstet Gynecol. 1989;  73 357-362
    PubMedSearch in Google Scholar
  • 38 Newlands E S, Bagshawe K D, Begent R H, Rustin G J, Holden L, Dent J. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979 - 1984).  Br J Obstet Gynaecol. 1986;  93 63-69
    PubMedSearch in Google Scholar
  • 39 Wong L C, Choo Y C, Ma H K. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease.  Gynecol Oncol. 1986;  23 87-93
    CrossrefPubMedSearch in Google Scholar
  • 40 Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).  Gynecol Oncol. 1988 Nov;  31 439-444
    PubMedSearch in Google Scholar
  • 41 Schink J C, Singh D K, Rademaker A W, Miller D S, Lurain J R. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.  Obstet Gynecol. 1992;  80 817-820
    PubMedSearch in Google Scholar
  • 42 Soper J T, Evans A C, Conaway M R, Clarke-Pearson D L, Berchuck A, Hammond C B. Evaluation of prognostic factors and staging in gestational trophoblastic tumor.  Obstet Gynecol. 1994;  84 969-973
    PubMedSearch in Google Scholar
  • 43 Surwit E A, Childers J M. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.  J Reprod Med. 1991;  36 45-48
    PubMedSearch in Google Scholar
  • 44 Bagshawe K D, Dent J, Newlands E S, Begent R H, Rustin G J. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumors.  Brit J Obstet Gynaecol. 1989;  96 795-802
    PubMedSearch in Google Scholar
  • 45 McNeish I A, Strickland S, Holden L, Rustin G J, Foskett M, Seckl M J, Newlands E S. Low-risk peristent gestational trophoblastic disaese: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.  J Clin Oncol. 2002;  20 838-844
    PubMedSearch in Google Scholar
  • 46 Roberts J P, Lurain J R. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.  Am J Obstet Gynecol. 1996;  174 1917-1923
    PubMedSearch in Google Scholar
  • 47 Berkowitz R S, Goldstein D P. Gestational trophoblastic disease.  Cancer. 1995;  76: (Suppl 10) 2079-2085
    PubMedSearch in Google Scholar
  • 48 Lurain J R. Treatment of gestational trophoblastic tumors.  Curr Treat Options Oncol. 2002;  3 113-124
    CrossrefPubMedSearch in Google Scholar
  • 49 Dobson L S, Lorigan P C, Coleman R E, Hancock B W. Persistent gestational trophoblastic disease: Results of MEA (methotrexate, etoposide and dactinomycine) as first-line chemotherapy in hight risk disease and EA (etoposide and dactinomycine) as second-line therapy for low risk disease.  Brit J Cancer. 2000;  82 1547-1552
    PubMedSearch in Google Scholar
  • 50 Bower M, Paradinas F J, Fisher R A, Nicholson S K, Rustin G J, Begent R H, Bagshawe K D, Newlands E S. Placental site trophoblastic tumor: Molecular analysis and clinical experience.  Clin Cancer Res. 1996;  2 897-902
    PubMedSearch in Google Scholar